Condition: Primary Open Angle Glaucoma · Sponsor: Amydis Inc.
The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).
This description comes directly from the study's public registry record.
Joyce Simpauco · 858-254-7435 · joyce@amydis.com
David Bingaman · david.bingaman@amydis.com
Always discuss trial participation with your own doctor first.
| Associated Retina Consultants | Phoenix, Arizona, United States | Recruiting |
| Global Research Management | Glendale, California, United States | Recruiting |
| Eye Research Foundation | Newport Beach, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06223048